Use of a copper intrauterine device by nulliparous women was not associated with an increased risk of tubal infertility

2002 ◽  
Vol 4 (2) ◽  
pp. 86-87
Author(s):  
Helen A. Doll ◽  
Martin P. Vessey
2020 ◽  
Vol 46 (1) ◽  
pp. 17-25 ◽  
Author(s):  
Philip C Hannaford ◽  
Angeline Ti ◽  
Tsungai Chipato ◽  
Kathryn M Curtis

ObjectivesTo review systematically copper intrauterine device (Cu-IUD) use and HIV acquisition in women.MethodsWe searched Pubmed, Embase and the Cochrane Library between database inception and 26 June 2019 for longitudinal studies comparing incident HIV infection among women using an unspecified IUD or Cu-IUD compared with non-hormonal or no contraceptive users, or hormonal contraceptive users. We extracted information from included studies, assessed study quality, and summarised study findings.ResultsFrom 2494 publications identified, seven met our inclusion criteria. One randomised controlled trial (RCT), judged “informative with few limitations”, found no statistically significant differences in HIV risk between users of the Cu-IUD and either intramuscular depot medroxyprogesterone acetate (DMPA-IM) or levonorgestrel implant. One observational study, deemed “informative but with important limitations”, found no statistically significant difference in HIV incidence among IUD users compared with women who had tubal ligation or who were not using any contraception. Another “informative but with important limitations” observational study found no difference in HIV incidence between Cu-IUD users and DMPA or norethisterone enanthate injectable, or implant users. An RCT considered “unlikely to inform the primary question” also found no difference in HIV risk between Cu-IUD and progestogen-only injectable users. Findings from the other three “unlikely to inform the primary question” cohort studies were consistent with the more robust studies suggesting no increased risk of HIV acquisition among Cu-IUD users.ConclusionThe collective evidence, including that from a large high-quality RCT, does not indicate an increased risk of HIV acquisition among users of Cu-IUDs.


2019 ◽  
Vol 221 (6) ◽  
pp. 672
Author(s):  
K. Peebles ◽  
F.M. Kiweewa ◽  
T. Palanee-Phillips ◽  
C. Chappell ◽  
D. Singh ◽  
...  

2018 ◽  
Vol 36 (05) ◽  
pp. 449-454
Author(s):  
Daniel Pasko ◽  
Kathryn Miller ◽  
Victoria Jauk ◽  
Akila Subramaniam

Objective We sought to evaluate differences in pregnancy outcomes following early amniotomy in women with class III obesity (body mass index ≥40 kg/m2) undergoing induction of labor. Study Design This is a retrospective cohort study of women with class III obesity undergoing term induction of labor from January 2007 to February 2013. Early amniotomy was defined as artificial membrane rupture at less than 4 cm cervical dilation. The primary outcome was cesarean delivery. Secondary outcomes included length of labor, a maternal morbidity composite, and a neonatal morbidity composite. A subgroup analysis examined the effect of parity. Multivariable logistic regression was used to adjust for covariates. Results Of 285 women meeting inclusion criteria, 107 (37.5%) underwent early amniotomy and 178 (62.5%) underwent late amniotomy. Early amniotomy was associated with cesarean delivery after multivariable adjustments (adjusted odds ratio [aOR], 2.05; 95% confidence interval [CI], 1.21–3.47). There were no significant differences in length of labor or maternal and neonatal morbidity between groups. When stratified by parity, early amniotomy was associated with increased cesarean delivery (aOR, 3.10; 95% CI, 1.47–6.58) only in nulliparous women. Conclusion Early amniotomy among class III obese women, especially nulliparous women, undergoing labor induction may be associated with an increased risk of cesarean delivery.


2018 ◽  
Vol 31 (2) ◽  
pp. 168
Author(s):  
Melissa Dundas ◽  
April Lee ◽  
Edward McCabe ◽  
Seleshi Demissie ◽  
Anthony Gonzalez

Sign in / Sign up

Export Citation Format

Share Document